摘要
目的:探讨生长抑素对肝癌切除术后患者肝功能及病情的影响。方法:以我院于2014年2月—2016年2月间收治的40例肝癌伴肝硬化患者为研究对象,随机分为对照组和观察组各20例。给予对照组肝癌切除术后的常规治疗,给予观察组生长抑素治疗,对比两种治疗方法的临床效果。结果:观察组的术后第3、5、7天的腹腔引流量、肝功能改善以及住院时间均优于对照组,两组差异有统计学意义(P<0.05)。结论:生长抑素能够减少肝癌切除术后患者的肝功能损害情况,效果显著,值得推广和应用。
Objective:To investigate the effect of somatostatin on liver function and disease after hepatectomy.Methods:Forty patients with hepatocellular carcinoma and cirrhosis treated in our hospital from February 2014 to February 2016 were randomly divided into control group and observation group.The patients in the control group were treated with conventional therapy of hepatectomy and treated with somatostatin.The clinical effects of the two methods were compared.Results:The intraperitoneal drainage volume,liver function and hospitalization time of the observation group were better than those of the control group on the 3rd,5th and 7th day after operation.The difference was statistically significant(P <0.05).Conclusion:Somatostatin can decrease the liver function damage after hepatectomy.The effect is significant,and it is worth to be popularized and applied.
关键词
生长抑素
肝癌切除术
肝功能
病情影响
Somatostatin
Hepatocellular carcinoma resection
Liver function
